RESILIENCE PROCURES $800 MN TO TRANSFORM U.S. HEALTHCARE

Highlights

• The company will be primarily invest in the development of new manufacturing technologies across cell and gene therapies, vaccines, viral vectors and proteins

• COVID-19 has exposed critical vulnerabilities in medical supply chains, and today’s man...